Drug Information

Drug General Information
Drug ID
D09OTG
Former ID
DCL000888
Drug Name
MS-377
Drug Type
Small molecular drug
Indication Schizophrenia [ICD9: 295; ICD10:F20] Terminated [536463]
Company
Schering AG
Structure
Download
2D MOL

3D MOL
Formula
C18H26ClN3O2
Canonical SMILES
COCCN1CCN(CC1)CC2CCN(C2=O)C3=CC=C(C=C3)Cl
InChI
1S/C18H26ClN3O2/c1-24-13-12-20-8-10-21(11-9-20)14-15-6-7-22(18(15)23)17-4-2-16(19)3-5-17/h2-5,15H,6-14H2,1H3/t15-/m1/s1
InChIKey
DKVVPXLIRYCKCS-OAHLLOKOSA-N
PubChem Compound ID
9892249
PubChem Substance ID
45639184, 74479819, 108136270, 127749281, 134339341, 225057542, 226784979
ChEBI ID
ChEBI:10003
SuperDrug ATC ID
J01GB10
SuperDrug CAS ID
cas=025546650
Target and Pathway
Target(s) Sigma(1)-type opioid receptor Target Info Antagonist [536463]
WikiPathways miR-targeted genes in squamous cell - TarBase
miR-targeted genes in lymphocytes - TarBase
References
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.